Doehn, C <br/><br/>
[Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?].  [electronic resource] 

 -  Der Urologe. Ausg. A  Oct 2007 
 - 1371-2, 1374, 1376-8 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0340-2592 
<br/><br/><label>Standard No.: </label>10.1007/s00120-007-1540-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cancer Vaccines--administration & dosage<br/>Carcinoma, Renal Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Clinical Trials, Phase III as Topic<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--drug therapy<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Nephrectomy<br/>Survival Rate